November 3, 2021 by Chain Drug Review
PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) Ppresident and CEO JC Scott issued the following statement on Congress’ agreement on drug pricing language for the budget bill: “We appreciate congressional negotiators’ focus on prescription drug prices and applaud inclusion of repeal of the rebate rule, a rule which threatens to dramatically increase premiums for Medicare
August 3, 2021 by Chain Drug Review
PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the proposed amendment by Senator Mike Braun (R, Ind.) in the Bipartisan Infrastructure Framework (BIF) legislation: “The Senate’s inclusion of a provision to delay the Medicare rebate rule in the infrastructure legislation is a good start to full
July 1, 2021 by Chain Drug Review
along with the pharmacy associations of seven states within the jurisdiction of the Eighth Circuit:, PCMA, The parties to the amicus brief are the National Community Pharmacists Association (NCPA) and the American Pharmacists Association (APhA)
Pharmacy
ALEXANDRIA, Va. – A group of nine pharmacy associations filed a friend of the court (amicus curiae) brief in the Eighth Circuit of the U.S. Court of Appeals today defending North Dakota’s right to regulate pharmacy benefit managers (PBMs). The parties to the amicus brief are the National Community Pharmacists Association (NCPA) and the American Pharmacists
January 26, 2021 by Chain Drug Review
PCMA, The Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has filed a motion for summary judgment to vacate the effective date of the Trump Administration’s rebate rule. The motion for summary judgment, filed in the U.S. District Court for the District of Columbia, seeks to vacate the January 1, 2022 effective date for the rebate rule
January 25, 2021 by Chain Drug Review
PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — A new report, “Pharmacy Services Administrative Organizations (PSAOs) and their Little-Known Connection to Independent Pharmacies,” sheds light on the role of PSAOs in the prescription drug supply and payment chain. The white paper, researched and written by the health care policy consulting firm Health Evaluations and released by the Pharmaceutical Care Management Association
November 20, 2020 by Chain Drug Review
PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON— Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration and Health and Human Services (HHS) Secretary Alex Azar finalizing the rebate rule (Removal of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection): “Simply put, the HHS Secretary’s
November 9, 2020 by Chain Drug Review
2020 Presidential election, JC Scott, PCMA
Leading Headlines, Pharmacy
WASHINGTON — PCMA president and CEO JC Scott issued the following statement on the 2020 presidential election: “The Pharmaceutical Care Management Association, representing America’s pharmacy benefit managers (PBMs) congratulates the President-elect and looks forward to working with the new Administration on lowering prescription drug costs for all Americans. “We appreciate the stated focus of the
September 8, 2020 by Chain Drug Review
Medicare, Alex Brill of Matrix Global Advisors (MGA), PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — A new report, “Negative Economic Impact of Restricting Rebates in Medicare Part D,” by Alex Brill of Matrix Global Advisors (MGA), examines recent evidence showing that prescription drug rebates negotiated by pharmacy benefit managers (PBMs) reduce drug costs and lower premiums in Medicare Part D. The paper concludes that proposed government action to
August 27, 2020 by Chain Drug Review
JC Scott, PCMA
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the reported “counteroffer” by the pharma lobby to the Administration: “While we remain deeply engaged in seeking solutions to lower drug prices and are as eager as anyone to see more progress, as reported, the ‘counteroffer’ that has
July 28, 2020 by Chain Drug Review
PCMA, Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott, President Trump’s Executive Order to revive the so-called rebate rule
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of a TV and digital advertising campaign on President Trump’s Executive Order to revive the so-called rebate rule. The campaign warns policymakers and the public that the Administration’s plan will drastically increase Medicare premiums for America’s seniors and most vulnerable. Click here to view the
March 27, 2020 by Chain Drug Review
COVID-19, JC Scott, PCMA
Leading Headlines, Pharmacy
WASHINGTON — On Thursday, members of the prescription drug supply and payment chain, including pharmacy benefit managers (PBMs), pharmaceutical manufacturers, pharmacies, including specialty and managed care pharmacies, and health plans, sent a letter to Vice President Mike Pence and congressional leaders affirming the safety and resiliency of the drug supply chain, and calling for public-private
March 17, 2020 by Chain Drug Review
CVS, Dr. Alan Lotvin, Drew Asher, Envolve Pharmacy Solutions, PCMA
Leading Headlines, Pharmacy
WASHINGTON— The Pharmaceutical Care Management Association (PCMA) announced that Drew Asher will be joining PCMA’s board of directors. He is the chief executive officer of Envolve Pharmacy Solutions. PCMA is the national association representing America’s pharmacy benefit managers (PBMs) which administer prescription drug plans for more than 266 million Americans with health coverage through Fortune
March 11, 2020 by Chain Drug Review
JC Scott, PCMA, Pharmaceutical Care Management Association (PCMA), Regina Stivers
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has announced that Regina Stivers as PCMA’s newest staff addition. Stivers joins PCMA as director, state affairs. She brings a tremendous amount of experience, having worked in both federal and state government and in the private sector overseeing economic development. Before joining PCMA, Regina served as both
February 26, 2020 by Chain Drug Review
JC Scott, PBMs, PCMA
Leading Headlines, Pharmacy
WASHINGTON — Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person per year, according to a new analysis by Visante, a $21 increase from 2016. The research also highlights PBMs’ role in reducing medication errors and improving patients’ health through increased adherence rates and specialty pharmacies. “As prescription drug prices